Back to mobile site

More on BNTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-26.9% Growth)
- Ratings (7.4 Score)

Upcoming Events

- Earnings (8/4/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

BioNTech SE (NQ:BNTX)
Delayed: 93.92 +0.87 (0.93%)
Prev. Close $93.05  
Open$93.29 
52 Wk High$ 
52 Wk Low$ 
Day High$94.00 
Day Low$92.56 
P/E N/A  
EPS$ 
Volume545,570 

Friends, Peers and Foes (?): 0A3M, PFE, MRNA, CVAC, NVAX (more...)

Jun 26, 2026 09:11 AM Form 3 BioNTech SE For: Jun 26 Filed by: Low-Friedrich Iris Katharina
Jun 26, 2026 09:09 AM Form 3 BioNTech SE For: Jun 26 Filed by: Schaffert Susanne
Jun 25, 2026 11:40 AM The New War on Cancer: Four Public Companies Helping Lead a Medical Revolution
Jun 15, 2026 06:08 AM German government to drop variable drug discounting plans - Reuters
Jun 8, 2026 08:01 AM Form 6-K BioNTech SE For: Jun 08
Jun 5, 2026 09:00 AM Bernstein SocGen Group Reiterates Market Perform Rating on BioNTech (BNTX)
Jun 3, 2026 01:17 PM Lilly cuts Germany investment plan in half over healthcare reforms
Jun 3, 2026 09:29 AM The Multi-Billion-Dollar Search for Better Glioblastoma Treatments
Jun 1, 2026 08:00 AM Form 6-K BioNTech SE For: Jun 01
May 28, 2026 04:07 PM JPMorgan says large-cap biotech is back as profits and pipelines fuel upside
View All Articles

Entities mentioned with BNTX

View All Entities